KeithKayeMD
Infectious Disease • Ann Arbor, MIProfessor, Internal Medicine, Wayne State University SOM
Dr. Kaye is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 East Medical Center Drive
Ann Arbor, MI 48109Phone+1 313-745-7105Fax+1 313-993-0302
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 1997 - 2000- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1994 - 1997
Perelman School of Medicine at the University of PennsylvaniaClass of 1994
Certifications & Licensure
NJ State Medical License 2021 - 2025
MI State Medical License 2008 - 2024
NC State Medical License 2000 - 2009- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME) Start of enrollment: 2012 Oct 06
- Optimizing Clinical Use of Polymyxin B Start of enrollment: 2016 Feb 01
- Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated Infection Start of enrollment: 2017 Jul 07
Publications & Presentations
PubMed
- 58 citationsAntimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011-2019: Rising ESBL Strains and Impac...Keith S Kaye, Vikas Gupta, Aruni Mulgirigama, Ashish V Joshi, Nicole E. Scangarella-Oman
Clinical Infectious Diseases. 2021-06-18 - 333 citationsDiabetes and Risk of Surgical Site Infection: A Systematic Review and Meta-analysis.Emily T. Martin, Keith S. Kaye, Caitlin Knott, Huong Nguyen, Maressa Santarossa
Infection Control and Hospital Epidemiology. 2016-01-01 - 42 citationsPolymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changesRajnikant Sharma, Saloni Patel, Cely S. Abboud, John K. Diep, Neang S. Ly
International Journal of Antimicrobial Agents. 2017-02-01
Journal Articles
- Epidemiology of Diabetic Foot Infection in the Metro-Detroit Area with a Focus on Independent Predictors for Pathogens Resistant to Recommended Empiric Antimicrobial T...Keith S Kaye, Paul E Kilgore, Kathryn Deeds, Rahul Pansare, Bushra Joarder, Sorabh Dhar, Open Forum Infectious Diseases
- Ceftazidime/avibactam, Meropenem/vaborbactam or Both? Clinical and Formulary ConsiderationsRobert A Bonomo, Keith S Kaye, Clinical Infectious Diseases
Lectures
- Internal Medicine Update: Inpatient & Outpatient Care for the Hospitalist & PCPAmerican Medical Seminars, Inc., Sarasota, Florida - 11/21/2011
- A Systematic Review and Meta-analysis of the Association between Hyperglycemia and Surgical Site InfectionsDetroit, MI - 6/15/2014
Other
- Infections and antimicrobial resistance in the intensive care unitKaye K, Marchaim D
http://www.uptodate.com/contents/infections-and-antimicrobial-resistance-in-the-intensive-care-unit
UpToDate, Wolters Kluwer Health - 2012-10-03
Press Mentions
Results from Pivotal Phase 3 ATTACK Trial of Investigational Sulbactam-Durlobactam for Treatment of Serious Infections Caused by Acinetobacter Published in the Lancet Infectious DiseasesMay 11th, 2023- FAQs: Improving Empiric Antibiotic Regimens for HABP/VABP in the ICUDecember 6th, 2022
- A New, More Effective UTI DrugNovember 23rd, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
